Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quetiapine as a Prophylactic Agent for Early Postoperative Delirium in High Risk Patients in Open Heart Surgeries

NCT05801289 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05801289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05801289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quetiapine as a Prophylactic Agent for Early Postoperative Delirium in High Risk Patients in Open Heart Surgeries
Lead sponsor
Ain Shams University
Phase
Not applicable
Overall status
Unknown status
Start date
December 4, 2022
Completion date
April 30, 2023
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delirium